Latest debt-to-equity ratio
Alnylam Pharmaceuticals Debt-to-equity ratio
Direct answer
Alnylam Pharmaceuticals's debt-to-equity ratio is 220.62%.
The verified market snapshot reports 220.62%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 220.62%
Explore related company data
View Alnylam Pharmaceuticals's market capitalizationView Alnylam Pharmaceuticals's p/e ratioView Alnylam Pharmaceuticals's price-to-book ratioView Alnylam Pharmaceuticals's return on equityView Alnylam Pharmaceuticals's dividend yieldView Alnylam Pharmaceuticals's 52-week price rangeView Alnylam Pharmaceuticals's revenue growthView Alnylam Pharmaceuticals's profit marginView all Alnylam Pharmaceuticals key metricsReturn to Alnylam Pharmaceuticals profile